Latest Breaking News On - உதவியாளர் ப்ரொஃபெஸர் பாபிடா மதன் - Page 1 : comparemela.com

Study could lead to the development of novel treatments for drug-resistant cancers ETC-159, a made-in-Singapore anti-cancer drug that is currently in early phase clinical trials for use in a subset of colorectal and gynecological cancers, could also prevent some tumors from resisting therapies by blocking a key DNA repair mechanism, researchers from Duke-NUS Medical School and the Agency for Science, Technology and Research (A STAR) in Singapore reported in the journal EMBO Molecular Medicine. Among the many therapies used to treat cancers, inhibitors of the enzyme poly (ADP ribose) polymerase (PARP) prevent cancer cells from repairing naturally occurring DNA damage, including unwanted/harmful breaks in the DNA. When too many breaks accumulate, the cell dies.

Ann leeDavid virshupEmily hendersonAgency for scienceExperimental drug development centreAssistant professor babita madanStem cell biologyProfessor david virshupDna damageMedical schoolStem cellsWnt signallingஆண்டு லீஎமிலி ஹென்டர்சன்சோதனை மருந்து வளர்ச்சி மையம்உதவியாளர் ப்ரொஃபெஸர் பாபிடா மதன்